Royal Bank of Canada’s CERo Therapeutics CERO Stock Holding History
Bought
Maintained
Sold
Royal Bank of Canada's CERO Position: Q4 2025 in Review
Royal Bank of Canada sold out of CERo Therapeutics (CERO) in Q4 2025, closing a stake of 1 share.
Royal Bank of Canada first reported a position in CERO in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 0 funds tracked by Wall St. Rank hold CERO as of Q4 2025.
- Royal Bank of Canada reported no remaining CERo Therapeutics position as of Q4 2025 after selling out during the quarter.
- Royal Bank of Canada sold 1 CERo Therapeutics share in Q4 2025.
- Royal Bank of Canada first reported a position in CERo Therapeutics in Q3 2025 and held it in 1 quarter.
- Royal Bank of Canada's CERo Therapeutics position peaked at $0 in Q3 2025.
- 0 funds tracked by Wall St. Rank held CERo Therapeutics as of Q4 2025.
Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.